Personalized medicine approach in mycobacterial disease

Por Mirsaeidi, Mehdi
Publicado em 2012

After 40 years, new medicine for combating TB

Por Mirsaeidi, Mehdi
Publicado em 2013

Rifampin induced angioedema: a rare but serious side effect

Por Mirsaeidi, Mehdi, Schraufnagel, Dean
Publicado no Braz J Infect Dis (2013)

Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis

Por Mirsaeidi, Mehdi, Sadikot, Ruxana T.
Publicado no Int J Mycobacteriol (2015)

Pneumococcal Vaccines: Understanding Centers for Disease Control and Prevention Recommendations

Por Mirsaeidi, Mehdi, Schraufnagel, Dean E.
Publicado em 2014

Health and Economy in COVID-19 Era: A Plan for Reconstituting Long-Term Economic Security

Por Allen, Mary Beth, Mirsaeidi, Mehdi
Publicado no Front Public Health (2020)

Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein - Barr virus in the Setting of HIV Infection

Por Mirsaeidi, Mehdi, Syed, Fatima, Jaffe, Elaine S.
Publicado em 2013

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen

Por Farshidpour, Maham, Ebrahimi, Golnaz, Mirsaeidi, Mehdi
Publicado em 2013

Nonsteroidal therapy of sarcoidosis

Por Korsten, Peter, Mirsaeidi, Mehdi, Sweiss, Nadera J.
Publicado em 2013

Response

Por Velayati, Ali Akbar, Farnia, Parissa, Mirsaeidi, Mehdi
Publicado no Chest (2015)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management

Por Mirsaeidi, Mehdi, Barletta, Pamela, Glassberg, Marilyn K.
Publicado no Front Med (Lausanne) (2019)

STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection

Por Gonzalez-Mancera, Miguel S., Johnson, Britt, Mirsaeidi, Mehdi
Publicado no Respir Med Case Rep (2020)

Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis

Por Mirsaeidi, Mehdi, Gidfar, Sanaz, Vu, Ann, Schraufnagel, Dean
Publicado no J Transl Med (2016)

COVID-19: Risk of alcohol abuse and psychiatric disorders

Por Haddadi, Sara, Murthi, Mukunthan, Salloum, Ihsan, Mirsaeidi, Mehdi S.
Publicado no Respir Med Case Rep (2020)

Pneumococcal Vaccine and Patients with Pulmonary Diseases

Por Mirsaeidi, Mehdi, Ebrahimi, Golnaz, Allen, Mary Beth, Aliberti, Stefano
Publicado em 2014

Primary sclerosing cholangitis in common variable immune deficiency

Por Mahdavinia, Mahboobeh, Mirsaeidi, Mehdi, Bishehsari, Faraz, McGrath, Kris
Publicado no Allergol Int (2015)

Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance

Por Velayati, Ali Akbar, Farnia, Parissa, Mozafari, Mohadese, Mirsaeidi, Mehdi
Publicado no Biomed Res Int (2015)

Hospital costs in the US for pulmonary mycobacterial diseases

Por Mirsaeidi, Mehdi, Allen, Mary Beth, Ebrahimi, Golnaz, Schraufnagel, Dean
Publicado no Int J Mycobacteriol (2015)

The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis

Por Mirsaeidi, Mehdi, Omar, Hesham R., Ebrahimi, Golnaz, Campos, Micheal
Publicado no Int J Hypertens (2016)

Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor

Por Au, Sonoa, Mirsaeidi, Mehdi, Aronson, Iris K, Sweiss, Nadera J.
Publicado no Sarcoidosis Vasc Diffuse Lung Dis (2014)